# Clinical review — PR pathway-wiring-fixes-p1-p5

**Decision:** approve
**Reviewer:** clinical-reviewer (model: claude-opus-4)
**Date:** 2026-06-03

## Scope
- Claims touched: none
- Citations affected: none
- Surfaces changed: clinical-pathway interactive UI; (Change 1) generated EMR-note text
- Evidence-verifier packet: not applicable
- Trial-statistician report: not applicable

## Semantic validity
No clinical claim text, dose, threshold, drug name, or interpretation string was added or modified. Verified directly in both files.

Change 1 (Status Epilepticus, src/pages/StatusEpilepticusPathway.tsx, Stage 2 "Seizure Stopped" button ~line 654): the prior `setStage1Success(true)` was a state-wiring defect that recorded the wrong stage. The corrected handler `setStage2Success(true); setStage2ActualAgent(finalStage2)` mirrors the sibling "Persists — Refractory" handler (line ~661) without advancing to Stage 3 — correct, because seizure cessation means no refractory escalation is warranted. The EMR builder (line ~193) now appends "(Responsive)" to the Stage 2 line, with the agent resolved as `stage2ActualAgent || finalStage2` (line ~192). The note accurately records that the second-line ESETT agent stopped the seizure. The fix makes EMR documentation more accurate, not less.

Change 2 (Clinic Headache, src/pages/ClinicHeadachePathway.tsx): removed a developer "Diagnostic (temporary)" debug strip (V-requested 2026-05-27, flagged for removal post-tuning, removal approved by product owner). It exposed only phenotype-evaluator internals — no ICHD-3 guidance, no recommendation, no clinician-facing claim. Result cards (`evaluateHeadachePhenotypes`) and footer citations untouched.

## Citation accuracy
No citations touched; none under `src/lib/citations/` modified.

## Editorial / expert context (REQUIRED for new-trial-entry PRs)
Not applicable — no new trial entry in this PR.

## Freshness
Not applicable — no citation `last_reviewed` fields touched; no freshness window affected.

## Rationale
Both changes are bug/cruft fixes on interactive pathway UI with no alteration to clinical claim text, dosing, thresholds, interpretation strings, or citations. Change 1 corrects a state flag so the EMR note now faithfully documents Stage 2 resolution and the actual second-line agent — a net documentation-accuracy improvement. Change 2 removes a leaked debug surface carrying no clinical guidance. No mandatory-block condition is met; no never-drift category is touched.

## Required follow-ups
- none
